Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Nanjing Ryon Biological Technology is a specialized biotechnology company focused on the development and manufacturing of high-quality raw materials for the in vitro diagnostic (IVD) industry. Headquartered in Nanjing, China, the company offers an extensive catalog of recombinant antigens, monoclonal antibodies, and enzymes tailored for applications in clinical chemistry, immunology, and molecular diagnostics. Ryon Bio provides critical components for assays targeting infectious diseases, cardiovascular markers, and inflammatory conditions. In addition to its product portfolio, the company offers contract services for protein expression and antibody engineering to support global diagnostic manufacturers. Their commitment to quality and technical support has established them as a key supplier in the life sciences research and diagnostic sectors.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Nanjing Ryon Biological Technology.